Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review @bradspellberg @lacuscmedcenter @usc

Superb work from Wald–Dickler and coworkers adding to the growing body of evidence that (to coin a phrase from senior author Brad Spellberg), shorter may be better and oral > IV. Background We sought to determine if controlled, prospective clinical data validate the long-standing belief that intravenous (IV) antibiotic therapy is required for the full […]

Read More Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review @bradspellberg @lacuscmedcenter @usc

Application and Clinical Effectiveness of Antibiotic-Loaded Bone Cement in the Treatment of Neuropathic Diabetic Foot Ulcers Complicated by Osteomyelitis: A Randomized Controlled Trial

Intriguing work by Ehya and coworkers. Abstract This study explored the clinical effectiveness of antibiotic-loaded bone cement on primary treatment of diabetic foot infection. This is a randomized controlled study, including thirty-six patients with diabetic foot ulcer complicated by osteomyelitis who had undergone treatment between May 2018 and December 2019. Patients were randomly divided into […]

Read More Application and Clinical Effectiveness of Antibiotic-Loaded Bone Cement in the Treatment of Neuropathic Diabetic Foot Ulcers Complicated by Osteomyelitis: A Randomized Controlled Trial

Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial @bradspellberg @limbsandlungs @alpslimb #ActAgainstAmputation

We look forward to this study and it’s resultant findings from our good friend and colleague Edgar Peters and coworkers Diabetic foot osteomyelitis (DFO) poses a major disease burden. It can generally be treated with long-term antibacterial therapy. International guidelines recommend to base antibacterial therapy choices on percutaneous bone biopsy culture, while in practice, therapy […]

Read More Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial @bradspellberg @limbsandlungs @alpslimb #ActAgainstAmputation

The Degree of Blood Supply and Infection Control Needed to Treat Diabetic Chronic Limb-Threatening Ischemia with Forefoot Osteomyelitis @USC_Vascular @JAPMAFeetTweets

untitled Miki Fujii, MD, PhD* Hiroto Terashi, MD, PhD† Koichi Yokono, MD, PhD‡ David G. Armstrong, DPM, MD, PhD§ Background: Diabetic foot ulcers combined with ischemia and infection can be difficult to treat. Few studies have quantified the level of blood supply and infection control required to treat such complex diabetic foot ulcers. We aimed […]

Read More The Degree of Blood Supply and Infection Control Needed to Treat Diabetic Chronic Limb-Threatening Ischemia with Forefoot Osteomyelitis @USC_Vascular @JAPMAFeetTweets

More specialties, fewer problems. How using “collaborative competencies” of Infectious Diseases, Podiatric Surgery and Pathology in teams improve care of diabetic foot osteomyelitis @japmafeettweets @idsainfo

Strong work from the superb team at the Beth Israel Deaconess in Boston. Look at the pre and post data on care of osteomyelitis! Bottom line: teamwork works, worldwide. Background: Diabetic Foot Osteomyelitis (DFO) is a common infection where treatment involves multiple services including Infectious Disease (ID), Podiatry, and Pathology. Despite its ubiquity in the hospital, […]

Read More More specialties, fewer problems. How using “collaborative competencies” of Infectious Diseases, Podiatric Surgery and Pathology in teams improve care of diabetic foot osteomyelitis @japmafeettweets @idsainfo